TIME COURSE OF CHANGES IN THE LEVEL OF C-TERMINAL TELOPEPTIDES DURING THERAPY IN PATIENTS WITH OSTEOARTHRITIS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The level of C-terminal telopeptides arising from collagen type II degradation during 3-month therapy using chondroitin sulfate (Structum), its combination with glucosamine hydrochloride (Artra) and Zeel T was estimated in patients with osteoarthritis. Better values were observed in gonarthrosis, particularly when Artra was used at the early stages of the disease; worse values were seen in Stage III osteoarthritis and its duration > 10 years.

Full Text

Restricted Access

About the authors

O. Maiko

Orenburg State Medical University

Email: omajko@yandex.ru
Professor, MD

E. Savelova

Orenburg State Medical University

Candidate of Medical Sciences

References

  1. Алексеева Л.И., Чичасова Н.В., Мендель О.И. Рациональный выбор базисной терапии при остеоартрозе. Результаты открытого рандомизированного многоцентрового исследования препарата АРТРА® в России // РМЖ. -2005; 13 (24): 1637-41.
  2. Каратеев А.Е. Гастродуоденальная безопасность селективных ингибиторов циклооксигеназы-2: проверка практикой // Тер. арх. - 2005; 5: 69-72.
  3. Каратеев А.Е., Алексеева Л.И., Братыгина Е.А. Оценка частоты развития побочных эффектов при длительном применении нимесулида в реальной клинической практике // РМЖ. - 2009; 17 (21): 1466-72.
  4. Майко О.Ю. Клинико-экономические аспекты применения нестероидных противовоспалительных и модифицирующих структуру хряща средств при остеоартрозе. Автореф. дис.. д-ра мед. наук. Оренбург, 2008; 43 с.
  5. Насонова В.А., Алексеева Л.И., Архангельская Г.С. и др. Итоги многоцентрового клинического исследования препарата структум в России // Тер. арх. - 2001; 11: 84-7.
  6. Насонова В.А. Остеоартроз: проблема полиморбидности // Consilium Medicum. - 2009; 11 (2): 234-45.
  7. Штрессер В., Вайзер М. Гомеопатическое лечение гонартроза: результаты двойного слепого исследования // Биол. медицина. - 2001; 2: 21-6.
  8. Эрдес Ш.Ф., Фоломеева О.М. Ревматические заболевания и инвалидность взрослого населения Российской Федерации // Научно-практическая ревматол. - 2007; 4: 4-9.
  9. Christgan S., Henrotin Y., Tanko L. Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate // Clin. Exp. Rheumatol. - 2004; 22 (1): 36-42.
  10. Ishijima M., Watari T., Naito K. et al. Relationships between biomarkers of cartilage, bone, synovial metabolism and knee pain provide insights into the origins of pain in early knee osteoarthritis // Arthritis Research & Therapy. -2011; 13 (1): 2.
  11. Jung M. Elevated urinary concentration of collagen type II C-telopeptide fragments in patients with osteoarthritis // Pathobiology. - 2004; 71 (2): 70-6.
  12. Hochberg M. Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration // Osteoarthritis Cartilage. - 2010; 18 (1): 28-31.
  13. Garnero P., Charni N., Juillet F. et al. Increased urinary type II collagen helical and C telopeptide levels are independently associated with a rapidly destructive hip osteoarthritis // Ann. Rheum. Dis. - 2006; 65: 1639-44.
  14. Gineyts E., Mo J., Ko A. et. al. Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis // Ann. Rheum. Dis. - 2004; 63: 857-61.
  15. Kahan A., Uebelhart D. et al. Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial // Arthr. Rheum. -2009; 60: 524-33.
  16. Manicourt D., Bevilacqua M., Righini V. et al. Comparative effect of nimesulide and ibuprofen on the urinary levels of collagen type II C-telopeptide degradation products and on the serum levels of hyaluronan and matrix metalloproteinases-3 and -13 in patients with flare-up of osteoarthritis // Drugs R.D. - 2005; 6: 261-71.
  17. Mazzuca S., Brandt K., Eyre D. et al. Urinary levels of type II collagen c-telopeptide crosslinks are unrelated to joint space narrowing in patients with knee osteoarthritis // Ann. Rheum. Dis. - 2006; 65: 1055-9.
  18. Marrona U., Weiser M., Klein P. Orale Behandlung der Gonarthrose mit Zeel compositum // Orthop. Praxis. - 2000; 5: 285-91.
  19. Oestergaard S., Chouinard L., Doyle N. et al. Early elevation in circulating levels of C-telopeptides of type II collagen predicts structural damage in articular cartilage in the rodent model of collagen-induced arthritis // Arthr. Rheum. - 2006; 54: 2886-90.
  20. Rozendaal R., Uitterlinden E. et al. Glucosamine sulphate effects on joint space narrowing, pain and function in patients with hip osteoarthritis; subgroup analyses of a randomized controlled trial // Osteoarthritis Cartilage. - 2009; 17: 427-32.
  21. Reijman M., Hazes J., Bierma-Zeinstra S. A new marker for osteoarthritis: cross-sectional and longitudinal approach // Arthr. Rheum. - 2004; 50; 2471-8.
  22. Sharif M., Kirwan J., Charni N. et al. A 5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis-association with disease progression // Rheumatology. - 2007; 46: 938-43.
  23. Zhang W., Nuki G., Moskowitz R. et al. OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009 // Osteoarthritis Cartilage. - 2010; 18: 476-99.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2016 Russkiy Vrach Publishing House

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies